Financhill
Sell
28

NEP Quote, Financials, Valuation and Earnings

Last price:
$17.62
Seasonality move :
-0.63%
Day range:
$16.93 - $17.68
52-week range:
$15.55 - $35.15
Dividend yield:
20.42%
P/E ratio:
8.08x
P/S ratio:
1.41x
P/B ratio:
0.48x
Volume:
1.5M
Avg. volume:
1.9M
1-year change:
-40.77%
Market cap:
$1.6B
Revenue:
$1.1B
EPS (TTM):
$2.18
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Revenue $855M $917M $722M $969M $1.1B
Revenue Growth (YoY) 10.9% 7.25% -21.27% 34.21% 11.25%
 
Cost of Revenues $336M $363M $374M $527M $520M
Gross Profit $519M $554M $348M $442M $558M
Gross Profit Margin 60.7% 60.41% 48.2% 45.61% 51.76%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin -- -- -- -- --
Other Inc / (Exp) $39M $108M $184M $274M $165M
Operating Expenses $286M $299M $279M $434M $586M
Operating Income $233M $255M $69M $8M -$28M
 
Net Interest Expenses $702M $620M -- -- $394M
EBT. Incl. Unusual Items -$430M -$257M $303M $1.1B -$257M
Earnings of Discontinued Ops. -- -- $158M $152M $450M
Income Tax Expense -$26M -$19M $37M $161M -$25M
Net Income to Company -$404M -$238M $424M $1.1B $218M
 
Minority Interest in Earnings $333M $188M -$287M -$644M -$18M
Net Income to Common Excl Extra Items -$71M -$50M $137M $477M $200M
 
Basic EPS (Cont. Ops) -$1.51 -$0.81 $1.77 $5.62 $2.18
Diluted EPS (Cont. Ops) -$1.51 -$0.81 $1.77 $5.62 $2.18
Weighted Average Basic Share $58.8M $68.4M $77.2M $84.9M $91.6M
Weighted Average Diluted Share $58.8M $68.4M $77.4M $84.9M $91.6M
 
EBITDA $603M $737M $474M $581M $772M
EBIT $272M $363M $69M $8M $137M
 
Revenue (Reported) $855M $917M $722M $969M $1.1B
Operating Income (Reported) $233M $255M $69M $8M -$28M
Operating Income (Adjusted) $272M $363M $69M $8M $137M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $240M $252M $302M $308M $319M
Revenue Growth (YoY) -5.14% 5% 19.84% 1.99% 3.57%
 
Cost of Revenues $93M $110M $153M $121M $128M
Gross Profit $147M $142M $149M $187M $191M
Gross Profit Margin 61.25% 56.35% 49.34% 60.71% 59.88%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin -- -- -- -- --
Other Inc / (Exp) $59M $60M $81M $72M $77M
Operating Expenses $79M $78M $108M $155M $156M
Operating Income $68M $64M $41M $32M $35M
 
Net Interest Expenses -- $24M -- -- $165M
EBT. Incl. Unusual Items $220M $100M $277M $128M -$53M
Earnings of Discontinued Ops. -- -- -- $32M --
Income Tax Expense $25M $6M $45M $28M $30M
Net Income to Company $195M $94M $233M $132M -$83M
 
Minority Interest in Earnings -$138M -$76M -$153M -$79M $43M
Net Income to Common Excl Extra Items $57M $18M $79M $53M -$40M
 
Basic EPS (Cont. Ops) $0.83 $0.24 $0.93 $0.57 -$0.43
Diluted EPS (Cont. Ops) $0.76 $0.24 $0.93 $0.57 -$0.43
Weighted Average Basic Share $67.7M $76.6M $85.1M $93.4M $93.5M
Weighted Average Diluted Share $75.9M $76.6M $85.6M $93.4M $93.5M
 
EBITDA $161M $225M $179M $198M $271M
EBIT $68M $124M $41M $32M $112M
 
Revenue (Reported) $240M $252M $302M $308M $319M
Operating Income (Reported) $68M $64M $41M $32M $35M
Operating Income (Adjusted) $68M $124M $41M $32M $112M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $911M $963M $916M $870M $1.2B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $363M $393M $490M $500M $520M
Gross Profit $548M $570M $426M $370M $647M
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin -- -- -- -- --
Other Inc / (Exp) $106M $176M $275M $180M $213M
Operating Expenses $299M $305M $392M $520M $619M
Operating Income $249M $265M $34M -$150M $28M
 
Net Interest Expenses $697M -- -- $199M $432M
EBT. Incl. Unusual Items -$342M $695M $1.1B -$169M -$191M
Earnings of Discontinued Ops. -- -- -- $96M $354M
Income Tax Expense -$28M $72M $161M -$9M $5M
Net Income to Company -$314M $623M $1.1B $88M $157M
 
Minority Interest in Earnings $237M -$413M -$631M $34M $46M
Net Income to Common Excl Extra Items -$77M $210M $433M $122M $204M
 
Basic EPS (Cont. Ops) -$1.32 $2.80 $5.11 $1.33 $2.18
Diluted EPS (Cont. Ops) -$1.44 $2.79 $5.11 $1.33 $2.18
Weighted Average Basic Share -- -- -- -- --
Weighted Average Diluted Share -- -- -- -- --
 
EBITDA $631M $768M $574M $553M $877M
EBIT $261M $382M $34M -$69M $241M
 
Revenue (Reported) $911M $963M $916M $870M $1.2B
Operating Income (Reported) $249M $265M $34M -$150M $28M
Operating Income (Adjusted) $261M $382M $34M -$69M $241M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $705M $751M $945M $846M $936M
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $274M $303M $418M $390M $390M
Gross Profit $431M $448M $527M $456M $546M
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin -- -- -- -- --
Other Inc / (Exp) $89M $156M $247M $153M $200M
Operating Expenses $225M $231M $346M $433M $466M
Operating Income $206M $217M $181M $23M $80M
 
Net Interest Expenses $839M $360M -- $218M $232M
EBT. Incl. Unusual Items -$435M $517M $1.3B -$18M $48M
Earnings of Discontinued Ops. -- -- -- $96M --
Income Tax Expense -$37M $54M $178M $8M $38M
Net Income to Company -$398M $463M $1.1B $70M $9M
 
Minority Interest in Earnings $284M -$317M -$661M $18M $82M
Net Income to Common Excl Extra Items -$114M $146M $442M $88M $92M
 
Basic EPS (Cont. Ops) -$1.85 $1.94 $5.26 $0.93 $0.98
Diluted EPS (Cont. Ops) -$1.94 $1.94 $5.26 $0.93 $0.98
Weighted Average Basic Share $198.7M $228.8M $252.9M $273M $280.5M
Weighted Average Diluted Share $217.2M $228.9M $253.5M $273.6M $280.5M
 
EBITDA $478M $603M $605M $577M $754M
EBIT $201M $314M $181M $104M $280M
 
Revenue (Reported) $705M $751M $945M $846M $936M
Operating Income (Reported) $206M $217M $181M $23M $80M
Operating Income (Adjusted) $201M $314M $181M $104M $280M
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Cash and Equivalents $128M $108M $147M $226M $274M
Short Term Investments -- -- -- -- --
Accounts Receivable, Net $79M $83M $112M $117M $114M
Inventory $20M $24M $41M $49M $82M
Prepaid Expenses -- -- -- -- --
Other Current Assets $16M $16M $25M $207M $107M
Total Current Assets $433M $414M $1.4B $1.9B $2.2B
 
Property Plant And Equipment $7B $7.2B $11.4B $14.2B $14.8B
Long-Term Investments $1.7B $1.8B $1.9B $1.9B $1.9B
Goodwill $609M $609M $891M $812M $833M
Other Intangibles $2.3B $2.2B $2.8B $2B $2B
Other Long-Term Assets $137M $131M $265M $2.3B $785M
Total Assets $12.3B $12.6B $19B $23.1B $22.5B
 
Accounts Payable $122M $143M $982M $867M $72M
Accrued Expenses $40M $25M $26M $28M $38M
Current Portion Of Long-Term Debt $12M $12M $33M -- --
Current Portion Of Capital Lease Obligations -- -- -- -- --
Other Current Liabilities $48M $82M $91M $283M $83M
Total Current Liabilities $301M $350M $1.3B $1.3B $1.7B
 
Long-Term Debt $4.1B $3.4B $5.3B $5.3B $4.9B
Capital Leases -- -- -- -- --
Total Liabilities $5.2B $4.9B $7.8B $8.3B $8.5B
 
Common Stock -- -- -- -- --
Other Common Equity Adj -- -- -- -- --
Common Equity $2.2B $2.4B $3B $3.3B $3.6B
Total Preferred Equity -- -- -- -- --
Minority Interest, Total $4.9B $5.4B $8.2B $11.4B $10.5B
Total Equity $7.1B $7.7B $11.2B $14.8B $14.1B
 
Total Liabilities and Equity $12.3B $12.6B $19B $23.1B $22.5B
Cash and Short Terms $128M $108M $147M $226M $274M
Total Debt $4.1B $3.4B $5.3B $5.3B $6.3B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Cash and Equivalents $95M $133M $225M $332M $290M
Short Term Investments -- -- -- -- --
Accounts Receivable, Net $89M $108M $127M $139M $116M
Inventory $25M $32M $46M $78M $102M
Prepaid Expenses -- -- -- -- --
Other Current Assets $16M $26M $88M $96M $145M
Total Current Assets $480M $635M $799M $1.1B $852M
 
Property Plant And Equipment $7B $7.2B $11.4B $15.7B $14.6B
Long-Term Investments $1.6B $1.8B $1.9B $2B $1.9B
Goodwill $609M $786M $891M $913M $828M
Other Intangibles $2.2B $2.5B $2.6B $2.5B $1.9B
Other Long-Term Assets $130M $289M $298M $452M $894M
Total Assets $12.3B $13.4B $18.5B $23.2B $20.9B
 
Accounts Payable $179M $23M $179M $280M $71M
Accrued Expenses $20M $17M $17M $34M $34M
Current Portion Of Long-Term Debt $13M $14M $37M -- --
Current Portion Of Capital Lease Obligations -- -- -- -- --
Other Current Liabilities $64M $75M $72M $73M $75M
Total Current Liabilities $363M $201M $419M $1.8B $422M
 
Long-Term Debt $3.9B $4B $4.8B $5.1B $5.1B
Capital Leases -- -- -- -- --
Total Liabilities $5.6B $5B $5.9B $8.8B $7.3B
 
Common Stock -- -- -- -- --
Other Common Equity Adj -- -- -- -- --
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total $4.4B $6.1B $9.2B $10.9B $10.2B
Total Equity $6.7B $8.4B $12.6B $14.4B $13.6B
 
Total Liabilities and Equity $12.3B $13.4B $18.5B $23.2B $20.9B
Cash and Short Terms $95M $133M $225M $332M $290M
Total Debt $3.9B $4B $4.8B $6.5B $5.2B
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Net Income to Stockholders -$404M -$238M $424M $1.1B $218M
Depreciation & Amoritzation $331M $374M $405M $573M $635M
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations $346M $665M $677M $776M $731M
 
Capital Expenditures $93M $334M $113M $1.4B $1.3B
Cash Acquisitions -$2.3B -$378M -$2.4B -$785M $1.2B
Cash From Investing -$2.3B -$681M -$2.3B -$1.2B -$194M
 
Dividends Paid (Ex Special Dividend) -$383M -$449M -$619M -$636M -$741M
Special Dividend Paid
Long-Term Debt Issued $3.4B $695M $2.9B $1.5B $2.4B
Long-Term Debt Repaid -$2.8B -$1.2B -$1.2B -$1.5B -$1.5B
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities $1.8B $914M $511M $1.1B -$940M
Cash From Financing $2B -$4M $1.7B $551M -$527M
 
Beginning Cash (CF) $166M $132M $112M $151M $284M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$34M -$20M $39M $133M $10M
Ending Cash (CF) $132M $112M $151M $284M $294M
 
Levered Free Cash Flow $253M $331M $564M -$575M -$538M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders $195M $94M $233M $132M -$83M
Depreciation & Amoritzation $93M $101M $138M $166M $159M
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations $223M $184M $202M $256M $208M
 
Capital Expenditures $115M $18M $209M $257M $56M
Cash Acquisitions -- -$800M -$179M -- --
Cash From Investing -$134M $55M $264M -$134M $596M
 
Dividends Paid (Ex Special Dividend) -$121M -$144M -$181M -$206M -$222M
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $7M $9M -- $315M $175M
Long-Term Debt Repaid -$2M -$3M -$486M -$329M -$777M
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities $26M -$80M $24M -$149M $45M
Cash From Financing -$90M -$218M -$498M -$369M -$779M
 
Beginning Cash (CF) $100M $116M $257M $628M $321M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$1M $21M -$32M -$247M $25M
Ending Cash (CF) $99M $137M $225M $381M $346M
 
Levered Free Cash Flow $108M $166M -$7M -$1M $152M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders -$314M $623M $1.1B $88M $157M
Depreciation & Amoritzation $370M $386M $540M $622M $636M
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations $576M $675M $796M $717M $696M
 
Capital Expenditures $290M $180M $989M $1.5B $394M
Cash Acquisitions -$1.3B -$1.2B -$1.5B -$1.4B $1.8B
Cash From Investing -$1.1B -$1.5B -$1.3B -$1.7B $1.7B
 
Dividends Paid (Ex Special Dividend) -$433M -$510M -$700M -$722M -$783M
Special Dividend Paid
Long-Term Debt Issued $1.8B $1.3B $2.3B $2.8B $1.2B
Long-Term Debt Repaid -$1.8B -$1.2B -$1.7B -$1.3B -$2.5B
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities $868M $1.3B $444M $46M -$343M
Cash From Financing $426M $830M $562M $1.2B -$2.4B
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$111M $38M $88M $156M -$35M
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow $286M $495M -$193M -$740M $302M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders -$398M $463M $1.1B $70M $9M
Depreciation & Amoritzation $277M $289M $424M $473M $474M
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations $482M $492M $611M $552M $517M
 
Capital Expenditures $236M $82M $958M $1.1B $189M
Cash Acquisitions -- -$800M $14M -$611M --
Cash From Investing -$283M -$1.1B -$38M -$564M $1.3B
 
Dividends Paid (Ex Special Dividend) -$326M -$387M -$468M -$554M -$596M
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $68M $624M $92M $1.4B $199M
Long-Term Debt Repaid -$17M -$98M -$616M -$349M -$1.3B
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities $41M $413M $346M -$687M -$90M
Cash From Financing -$232M $602M -$499M $109M -$1.8B
 
Beginning Cash (CF) $355M $341M $576M $1.2B $916M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$33M $25M $74M $97M $52M
Ending Cash (CF) $322M $366M $650M $1.3B $968M
 
Levered Free Cash Flow $246M $410M -$347M -$512M $328M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Will Iovance Biotherapeutics Stock Bounce Back?
Will Iovance Biotherapeutics Stock Bounce Back?

Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 21

Quantum [QMCO] is up 26.28% over the past day.

Sell
46
NUKK alert for Dec 21

Nukkleus [NUKK] is down 22.94% over the past day.

Sell
1
IIPR alert for Dec 21

Innovative Industrial Properties [IIPR] is down 22.7% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock